{"status": "Ok", "redirect_url": "https://www.businesswire.com/news/home/20260507663929/en/Bristol-Myers-Squibb-Receives-European-Commission-Approval-of-Sotyktu-deucravacitinib-for-the-Treatment-of-Active-Psoriatic-Arthritis-in-Adults", "message": "News view counter 713355 successfully enlarged"}